日本人原発性免疫不全症（PID）患者におけるTAK-771の長期安全性を評価する試験

基本情報

NCT ID

NCT05513586

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

15

治験依頼者名

Takeda

概要

The main aim of the study is to check side effect from the study treatment with TAK-771 in long term. Participants can have taken part in the previous study TAK-771-3004 (NCT05150340). For those who can take part, the participants will receive injections of TAK-771 after the end of the previous study. The participants will be treated with TAK-771 for totally 3 years. There will be many clinic visits. The number of visits will depend on the infusion cycles of study drug.

対象疾患

介入

依頼者（Sponsor）

実施施設 (9)